ImageneBio (IMA) Net Income (2020 - 2025)
ImageneBio (IMA) posted Net Income of -$24.8 million for Q3 2025, down 794.58% sequentially from -$2.8 million in Q2 2025, and down 677.66% YoY from $4.3 million in Q3 2024.
ImageneBio (IMA) Net Income (2020 - 2025) Analysis & Trends
ImageneBio has reported Net Income for 6 years, with the latest figure at -$24.8 million in Q3 2025.
- Quarterly Net Income fell 677.66% year-over-year to -$24.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$33.6 million (up 33.46% YoY) and the FY2024 annual result came in at -$49.2 million, up 27.77% from the prior year.
- Net Income eased to -$24.8 million in Q3 2025 per IMA's latest filing, from -$2.8 million in the prior quarter.
- Over five years, Net Income peaked at -$2.8 million in Q2 2025 and troughed at -$2.1 billion in Q2 2022.
- A 5-year average of -$191.6 million and a median of -$17.5 million in 2024 frame the typical range for Net Income.
- The sharpest annual moves came in 2022 and 2023: Net Income sank 3859.26% in 2022, then soared 99.2% in 2023.
- Over 5 years, Net Income stood at -$30.5 million in 2021, then surged by 47.96% to -$15.9 million in 2022, then retreated by 23.9% to -$19.7 million in 2023, then increased by 11.06% to -$17.5 million in 2024, then slumped by 41.62% to -$24.8 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$24.8 million, -$2.8 million, and -$6.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -13.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -355.03 Mn |
| 10 | ImageneBio | 48.60 Mn | -86.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -24.75 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Mar 31, 2025 | -6.11 Mn |
| Dec 31, 2024 | -17.48 Mn |
| Sep 30, 2024 | -3.18 Mn |
| Jun 30, 2024 | -13.73 Mn |
| Mar 31, 2024 | -16.15 Mn |
| Dec 31, 2023 | -19.65 Mn |
| Sep 30, 2023 | -17.34 Mn |
| Jun 30, 2023 | -17.12 Mn |
| Mar 31, 2023 | -14.22 Mn |
| Dec 31, 2022 | -15.86 Mn |
| Sep 30, 2022 | -1.05 Bn |
| Jun 30, 2022 | -2.14 Bn |
| Mar 31, 2022 | -22.57 Mn |
| Dec 31, 2021 | -30.48 Mn |
| Sep 30, 2021 | -49.38 Mn |
| Jun 30, 2021 | -54.15 Mn |
| Mar 31, 2021 | -121.50 Mn |
| Dec 31, 2020 | -31.52 Mn |